These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2685164)

  • 1. [Calcium inhibitors and arterial hypertension].
    Hugue C; Safar M
    J Mal Vasc; 1989; 14(4):356-9. PubMed ID: 2685164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium-entry blockers and arterial compliance in hypertension.
    Safar ME; Pannier B; Laurent S; London GM
    J Cardiovasc Pharmacol; 1989; 14 Suppl 10():S1-6; discussion S59-62. PubMed ID: 2483564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Iwasaka T
    J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large arteries in hypertension: acute effects of a new calcium entry blocker, nitrendipine.
    Levenson J; Simon AC; Safar ME; Bouthier J; Maarek BC
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1006-10. PubMed ID: 6085357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tissue selectivity of calcium channel blockers].
    Godfraind T
    C R Seances Soc Biol Fil; 1998; 192(1):121-35. PubMed ID: 9759358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential responses of the heart and vasculature to chronic blood pressure reduction in essential hypertension.
    Lafleche A; Gautier S; Topouchian J; Wilmet CS; Girerd X; Safar ME; Benetos A
    Clin Pharmacol Ther; 1998 Jul; 64(1):96-105. PubMed ID: 9695724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of calcium antagonists in the treatment of arterial hypertension].
    Velasco M; Negrín C
    Invest Clin; 1997 Nov; 38 Suppl 2():65-72. PubMed ID: 9471233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differential therapy with calcium antagonists].
    Scholze JE
    Herz; 2003 Dec; 28(8):754-63. PubMed ID: 14689111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are calcium antagonists the best option in elderly hypertensives?
    Forette F; Bert P; Rigaud AS
    J Hypertens Suppl; 1994 Sep; 12(6):S19-23. PubMed ID: 7799105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The actions and role of calcium entry blockers in hypertension: cardiac considerations.
    Sole MJ
    Clin Invest Med; 1989 Oct; 12(5):294-9. PubMed ID: 2689025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intervessel (arteries and veins) and heart/vessel selectivities of therapeutically used calcium entry blockers: variable, vessel-dependent indexes.
    Magnon M; Gallix P; Cavero I
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1157-66. PubMed ID: 8531077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment for one year with perindopril: effect on cardiac mass and arterial compliance in essential hypertension.
    Asmar RG; Journo HJ; Lacolley PJ; Santoni JP; Billaud E; Levy BI; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S33-9. PubMed ID: 3225688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcium antagonists in the treatment of chronic arterial hypertension and hypertensive crisis].
    Brandt D
    Wien Med Wochenschr; 1983 Mar; 133(6):131-5. PubMed ID: 6134398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antihypertensive treatment on small artery remodeling in hypertension.
    Schiffrin EL
    Can J Physiol Pharmacol; 2003 Feb; 81(2):168-76. PubMed ID: 12710531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drugs and arterial stiffness in hypertensive patients].
    Laurent S
    Drugs; 2003; 63 Spec No 1():1-8. PubMed ID: 12708878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaso-dilating drugs and the large arteries in essential hypertension.
    Safer ME; Levenson JA
    Artery; 1986; 14(1):1-27. PubMed ID: 2947552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vessel wall properties of large arteries in hypertension and effect of antihypertensive treatment.
    Van Bortel LM; Kool MJ
    Can J Cardiol; 1994 Nov; 10 Suppl D():37D-40D. PubMed ID: 7954040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arterial dynamics, cardiac hypertrophy, and antihypertensive treatment.
    Safar ME; Toto-Moukouo JJ; Bouthier JA; Asmar RE; Levenson JA; Simon AC; London GM
    Circulation; 1987 Jan; 75(1 Pt 2):I156-61. PubMed ID: 2947747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ACE inhibitors, calcium channel blockers and their combination on renal and extrarenal structures in renal failure.
    Amann K; Törnig J; Nichols C; Zeier M; Mall G; Ritz E
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():33-8. PubMed ID: 8643206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.